The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Microvascular Complications of Impaired Glucose Tolerance
Open accessAbstract
Impaired glucose tolerance (IGT) serves as a marker for the state of insulin resistance and predicts both large- and small-vessel vascular complications, independent of a patient’s progression to diabetes. Patients with IGT are at significantly increased risk for death and morbidity due to myocardial infarction, stroke, and large-vessel occlusive disease. IGT is more predictive of cardiovascular morbidity than impaired fasting glucose, probably because it is a better surrogate for the state of insulin resistance. IGT is also independently associated with traditional microvascular complications of diabetes, including retinopathy, renal disease, and polyneuropathy, which are the topics of this review. Inhibition of nitric oxide-mediated vasodilation, endothelial injury due to increased release of free fatty acids and adipocytokines from adipocytes, and direct metabolic injury of endothelial and end-organ cells contribute to vascular complications. Early detection of IGT allows intensive diet and exercise modification, which has proven significantly more effective than drug therapy in normalizing postprandial glucose and inhibiting progression to diabetes. To what degree intervention will limit recognized complications is not known.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hyperglycemia causes nerve toxicity, leading to nerve damage and apoptosis ( 242 , 244 ), which causes microvascular damage and loss of perfusion.”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [242]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,898
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,370
Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis
Harris, M. I., Klein, R., Welborn, T. A., & Knuiman, M. W. (1992) · Diabetes Care · doi:10.2337/diacare.15.7.815 · Cited by 1,306
Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., & Sekikawa, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.920 · Cited by 1,165
The spectrum of neuropathy in diabetes and impaired glucose tolerance
Sumner, C. J., Sheth, S., Griffin, J. W., Cornblath, D. R., & Polydefkis, M. (2003) · Neurology · doi:10.1212/wnl.60.1.108 · Cited by 708
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
Cameron, N. E., Eaton, S. E. M., Cotter, M. A., & Tesfaye, S. H. (2001) · Diabetologia · doi:10.1007/s001250100001 · Cited by 701
Kawano, H., Motoyama, T., Hirashima, O., Hirai, N., Miyao, Y., Sakamoto, T., Kugiyama, K., Ogawa, H., & Yasue, H. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00168-0 · Cited by 676
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
Caballero, A. E., Arora, S., Saouaf, R., Lim, S. C., Smakowski, P., Park, J. Y., King, G. L., LoGerfo, F. W., Horton, E. S., & Veves, A. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1856 · Cited by 647
Jiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stuehlinger, M. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 578
Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial Ischemia-Reperfusion
Gao, F., Gao, E., Yue, T.-L., Ohlstein, E. H., Lopez, B. L., Christopher, T. A., & Ma, X. (2002) · Circulation · doi:10.1161/01.cir.0000012529.00367.0f · Cited by 469
Balletshofer, B. M., Rittig, K., Enderle, M. D., Volk, A., Maerker, E., Jacob, S., Matthaei, S., Kristian, R. E. T. T., & Häring, H. U. (2000) · Circulation · doi:10.1161/01.cir.101.15.1780 · Cited by 437
Adiponectin: a link between excess adiposity and associated comorbidities?
Ukkola, O. H., & Santaniemi, M. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0378-7 · Cited by 369
Increased Prevalence of Impaired Glucose Tolerance in Patients With Painful Sensory Neuropathy
Singleton, J. R., Smith, A. G., & Bromberg, M. B. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1448 · Cited by 364
Self-citationHamdy, O., Ledbury, S., Mullooly, C., Jarema, C., Porter, S., Ovalle, K., Moussa, A., Caselli, A., Caballero, A. E., Economides, P. A., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2119 · Cited by 340
Protein kinase C and the development of diabetic vascular complications
Way, K. J., Katai, N., & King, G. L. (2001) · Diabetic Medicine · doi:10.1046/j.0742-3071.2001.00638.x · Cited by 313
Shankar, R. R., Yu-ling, W., Shen, H.-Q., Zhu, J. S., & Baron, A. (2000) · Diabetes · doi:10.2337/diabetes.49.5.684 · Cited by 297
SENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
Franklin, G. M., KAHN, L. B., Baxter, J. E., Marshall, J. A., & Hamman, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy
Thomas, P. (1997) · Diabetes · doi:10.2337/diab.46.2.s54 · Cited by 281
Isomaa, B., Henricsson, M., Almgren, P.-E., Tuomi, T., Taskinen, M., & Groop, L. (2001) · Diabetologia · doi:10.1007/s001250100615 · Cited by 260
Postprandial recruitment of neutrophils may contribute to endothelial dysfunction
van Oostrom, A. J. H. H. M., Sijmonsma, T. P., Verseyden, C., Jansen, E. H. J. M., de Koning, E. J. P., Rabelink, T. J., & Castro Cabezas, M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200419-jlr200 · Cited by 249
Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy
Smith, A. G., Ramachandran, P., Tripp, S., & Singleton, J. R. (2001) · Neurology · doi:10.1212/wnl.57.9.1701 · Cited by 235
Self-citationGabir, M. M., Hanson, R. L., Dabelea, D., Imperatore, G., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1113 · Cited by 211
Hexosamines as mediators of nutrient sensing and regulation in diabetes
McClain, D. A. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00188-x · Cited by 196
Microalbuminuria Precedes the Development of NIDDM
Mykkänen, L. M., Haffner, S. M., Kuusisto, J., Pyörälä, K., & Laakso, M. (1994) · Diabetes · doi:10.2337/diab.43.4.552 · Cited by 189
Kuller, L. H., Velentgas, P., Barzilay, J. I., Beauchamp, N. J., O’Leary, D. H., & Savage, P. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.823 · Cited by 181
Neurology and General Medicine
(2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06707-5.x5001-9 · Cited by 155
Association of Fasting Plasma Glucose With Heart Rate Recovery in Healthy Adults
Panzer, C., Lauer, M. S., Brieke, A., Blackstone, E. H., & Hoogwerf, B. J. (2002) · Diabetes · doi:10.2337/diabetes.51.3.803 · Cited by 149
Cohen, J. A., Jeffers, B. W., Faldut, D., Marcoux, M., & Schrier, R. W. (1998) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199801)21:1 · Cited by 103
FFA-Induced Endothelial Dysfunction Can Be Corrected by Vitamin C
Pleiner, J., Schaller, G., Mittermayer, F., Bayerle‐Eder, M., Roden, M., & Wolzt, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8596 · Cited by 87
Pan, X.-R., Hu, Y.-H., Li, G.-W., Liu, P.-A., Bennett, P. H., & Howard, B. V. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.150 · Cited by 77
Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity
Metcalf, P. A., Baker, J. R., Scragg, R. K. R., Dryson, E., Scott, A. J., & Wild, C. J. (1993) · Diabetes Care · doi:10.2337/diacare.16.11.1485 · Cited by 71
Higashi, Y., Oshima, T., Sasaki, N., Ishioka, N., Nakano, Y., Ozono, R., Yoshimura, M., Ishibashi, K., Matsuura, H., & Kajiyama, G. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.280 · Cited by 64
Klein, R., Barrett-Connor, E. L., Blunt, B. A., & Wingard, D. L. (1991) · Diabetes Care · doi:10.2337/diacare.14.10.914 · Cited by 62
Free Fatty Acid Overload Attenuates Ca 2+ Signaling and NO Production in Endothelial Cells
Esenabhalu, V. E., Schaeffer, G., & Graier, W. F. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603764816505 · Cited by 50
Microalbuminuria precedes the development of NIDDM
Mykkanen, L., Haffner, S. M., Kuusisto, J., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.4.552 · Cited by 43
Boyanovsky, B. B., Karakashian, A., King‐Pospisil, K., Giltiay, N. V., & Nikolova‐Karakashian, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301536200 · Cited by 34
Jonkers, I. J. A. M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00504-1 · Cited by 26
Alteration of Visual Function in Impaired Glucose Tolerance
Karadeniz, S., Kır, N., Yilmaz, M. T., Öngör, E., Dınççağ, N., Başar, D., Akarçay, K., Satman, İ., & Devrim, A. S. (1996) · European Journal of Ophthalmology · doi:10.1177/112067219600600112 · Cited by 20
The Relation of Fetal Growth to Insulin Secretion in Young Men
Wills, J., Watson, J. M., Hales, C. N., & Phillips, D. I. W. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199608)13:8 · Cited by 18
Changes in glucose tolerance during three years' follow-up in an elderly population
Hiltunen, L. A. (1999) · Public Health · doi:10.1016/s0033-3506(99)00150-x · Cited by 10
Changes in glucose tolerance during three years' follow-up in an elderly population
Hiltunen, L. A., Läärä, E., & Keinanen-Kiukaanniemi, S. M. (1999) · Public Health · doi:10.1038/sj.ph.1900553 · Cited by 8
Cited by
Sorted by citations
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955
“Hyperglycemia causes nerve toxicity, leading to nerve damage and apoptosis (242,244), which causes microvascular damage and loss of perfusion.”
Postprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945
Diabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 812
Self-citationGenome-Wide Association Study of Retinopathy in Individuals without Diabetes
Jensen, R. A., Sim, X., Li, X., Cotch, M. F., Ikram, M. K., Holliday, E. G., Eiríksdóttir, G., Harris, T. B., Jónasson, F., Klein, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054232 · Cited by 763
Self-citationAdiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Metadata
- Authors
- Singleton, J. R., Smith, A. G., Russell, J. W., & Feldman, E. L.
- Affiliations
- University of Utah (US)
- University of Michigan (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-12-01
- Volume
- 52
- Issue
- 12
- Pages
- 2867-2873
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2012946594
- Cited by
- 372
- References
- 50
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 13 · 2021: 12 · 2020: 14 · 2019: 15 · 2018: 12 · 2017: 15 · 2016: 8 · 2015: 20 · 2014: 21 · 2013: 13 · 2012: 27
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (NIH NS38849)
- Deutsches Krebsforschungszentrum
- National Institutes of Health (1r21ns041634-01)
- National Institute of Neurological Disorders and Stroke (NS40458, R01NS038849, NS42065, R01NS036778, R21-NS-41634, R01NS040458, K02NS042056, NS 36778)
- National Center for Research Resources (M01-RR00042NS38849, MO1-RR-00064, M01RR000064, M01RR000042)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- impaired glucose tolerance, microvascular complications, insulin resistance, cardiovascular risk, retinopathy, diabetic nephropathy, diabetic polyneuropathy, endothelial dysfunction, nitric oxide, adipokines, free fatty acids, prediabetes, diabetes prevention, diet and exercise intervention
- MeSH terms
- Diabetic Nephropathies, Diabetic Neuropathies, Diabetic Retinopathy, Humans, Microcirculation, Polyneuropathies, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
